Showing results (251-260 of 316) with videos related to

Sort By:
Pageof 32
Journal of Pain Research|September 4, 2023
Efficacy and Safety of Naloxegol in Patients with Chronic Non-Cancer Pain Who Experience Opioid-Induced Constipation: A Pooled Analysis of Two Global, Randomized Controlled StudiesWilliam D Chey, Darren M Brenner, Brooks D Cash, et al.
Digestive Diseases and Sciences|January 18, 2025
Low Utility of Routine Thyroid Function Testing for Bowel Symptoms: A Population-Based AssessmentAhmed D Elnaiem, Brent Hiramoto, Ryan Flanagan, et al.
Clinical and Translational Gastroenterology|November 5, 2024
Size of Pelvic Outlet as a Potential Risk Factor of Fecal Incontinence: A Population-Based Exploratory AnalysisBrent Hiramoto, Bryn E Falahee, Mayssan Muftah, et al.
Journal of Clinical Gastroenterology|August 12, 2022
Consider Hereditary Angioedema in the Differential Diagnosis for Unexplained Recurring Abdominal PainKyle Staller, Anthony Lembo, Aleena Banerji, et al.
Neurogastroenterology and Motility|April 24, 2025
Efficacy of Mediterranean Diet vs. Low-FODMAP Diet in Patients With Nonconstipated Irritable Bowel Syndrome: A Pilot Randomized Controlled TrialPrashant Singh, Gregory Dean, Sofia Iram, et al.
Inflammatory Bowel Diseases|November 14, 2024
Why Symptoms Linger in Quiescent Crohn's Disease: Investigating the Impact of Sulfidogenic Microbes and Sulfur Metabolic PathwaysJonathan Golob, Krishna Rao, Jeffrey A Berinstein, et al.
The American Journal of Gastroenterology|July 6, 2004
Tegaserod does not alter fasting or meal-induced biliary tract motilityRobert S Fisher, Johnson Thistle, Anthony Lembo, et al.
Medrxiv : the Preprint Server for Health Sciences|September 24, 2024
Why Symptoms Linger in Quiescent Crohn's Disease: Investigating the Impact of Sulfidogenic Microbes and Sulfur Metabolic PathwaysJonathan Golob, Krishna Rao, Jeffrey A Berinstein, et al.
Nature Reviews. Disease Primers|December 15, 2017
Chronic constipationMichael Camilleri, Alexander C Ford, Gary M Mawe, et al.
Blood Advances|February 24, 2025
Changes in acute care use among people with sickle cell disease after adoption of a prescription drug monitoring programBlake T McGee, Brandon K Attell, James Marton, et al.
Pageof 32